Skip to main content
. 2023 Mar 30;16:1115–1126. doi: 10.2147/JPR.S397777

Table 2.

PI-NRS of the Participants During Study Duration

Treatment [Mean (SD)] IP (n=27) p-value# Placebo (n=32) p-value# p-value*
Day 0 7.81 (1.04) 7.88 (1.04) 0.98
Day 7 6.89 (1.37) <0.0001 7.81 (0.93) 0.6875 0.006
Day 28 4.78 (1.40) <0.0001 7.81 (1.18) 0.8331 <0.0001
Day 42 3.04 (1.68) <0.0001 8.03 (1.06) 0.3593 <0.0001

Notes: *Between-group p-value was calculated using Mann Whitney U-test. #Within-group p-value was compared with baseline and calculated using Wilcoxon Signed Rank test (W).